BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETES
- 1 August 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 320 (8294), 354-357
- https://doi.org/10.1016/s0140-6736(82)90548-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- PRELIMINARY STUDIES ON THE IMMUNOGENICITY AND AMOUNT OF ESCHERICHIA COLI POLYPEPTIDES IN BIOSYNTHETIC HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGYThe Lancet, 1981
- Biosynthetic Human Insulin: Progress and ProspectsDiabetes Care, 1981
- Chemical, Physical, and Biologic Properties of Biosynthetic Human InsulinDiabetes Care, 1981
- Biologic and Immunologic in Vivo and In Vitro Studies with Biosynthetic Human InsulinDiabetes Care, 1981
- Pharmacokinetics of Biosynthetic Human Insulin and Characteristics of Its EffectDiabetes Care, 1981
- HUMAN INSULIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY: SAFETY AND HYPOGLYCÆMIC POTENCY IN HEALTHY MENThe Lancet, 1980
- Expression in Escherichia coli of chemically synthesized genes for human insulin.Proceedings of the National Academy of Sciences, 1979
- Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulinDiabetologia, 1978
- The clinical significance of highly purified pig-insulin preparationsDiabetologia, 1974
- Mean Amplitude of Glycemic Excursions, a Measure of Diabetic InstabilityDiabetes, 1970